Company: DMAAR
Filing Date: 2025-01-14
Form Type: POS AM
Source: 0001213900-25-003137
Chunk: 4

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-01-14
Form: POS AM
Chunk 4
---
 included in the private units as the “private rights.” The private units are identical to the units sold in this offering, subject to certain limited exceptions as described in this prospectus. Two institutional investors (none of which are affiliated with any member of our management, our sponsor or any other investor), which we refer to as the “non -managingsponsor investors” throughout this prospectus, have expressed an interest to indirectly purchase, through the purchase of non -managingsponsor membership interests, an aggregate of 50,000 of the 400,000 private units (or 430,000 private units if the underwriters’ over -allotmentoption is exercised in full) being purchased by our sponsor at a price of $10.00 per unit ($500,000 in the aggregate) in a private placement that will close simultaneously with the closing of this offering. Subject to each non -managingsponsor investor purchasing, through the sponsor, the private units allocated to it in connection with the closing of this offering, the sponsor will issue membership interests at a nominal purchase price to the non -managingsponsor investors reflecting interests in an aggregate of 666,667 founder shares held by the sponsor. The non -managingsponsor investors have expressed to us an interest in purchasing up to an aggregate of approximately $39.8million of the units in this offering at the offering price (assuming the exercise in full of the underwriters’ over -allotmentoption), or up to 19.9% of this offering. None of the non -managingsponsor investors has expressed to us an interest in purchasing more than 9.9% of the units to be sold in this offering, except one non -managingsponsor investor has expressed to us an interest in purchasing 19.9% of the units to be sold in this offering. There can be no assurance that the non -managingsponsor investors will acquire any units, either directly or indirectly, in this offering, or as to the amount of the units the non -managingsponsor investors will retain, if any, prior to or upon the consummation of our initial business combination. Because these expressions of interest are not binding agreements or commitments to purchase, non -managingsponsor investors may determine to purchase fewer units in this offering, more units in this offering, or none at all. In addition, the underwriters have full discretion to allocate the units to investors and may determine to sell fewer units to the non -man